As our knowledge of genetic variation impacting metabolic diseases continues to grow, clustering and other approaches will continue to refine our understanding of these critical endophenotypes, such as dysregulated insulin processing or unfavorable fat distribution. The gene discussed is INS; the disease is metabolic disease.